Pricing and Reimbursement

 

The reimbursement process is increasingly complex and gaining reimbursement from HTA authorities is a critical challenge. Rapid market access depends on an optimal strategy for price and reimbursement and early communication with national and local payers. Our pricing and reimbursement team has extensive experience from HTA authorities and offer expertise and knowledge of the value of a product from a payer’s perspective, which is essential to a successful reimbursement strategy. Our previous experience covers a wide range of products in all major therapeutic areas and all aspects of national pricing policies such as reference pricing and value based pricing.

The value of the right price

As the threshold for gaining reimbursement rises, the demand for proof of value and effectiveness of the product has become a crucial issue. The Nordic reimbursement legislations differ from country to country and payers such as county councils or pharmacy chains are adding to the complexity of getting reimbursement for a drug in the Nordic. Sofus helps with identifying and presenting evidence of product value and provides expert advice throughout the lifecycle of the product.

Sofus pricing and reimbursement team can help you with

  • pricing and reimbursement strategies – to support optimal value positioning, HTA assessment and pricing
  • advice regarding pricing aspects in early development phases to ensure payer-relevant outcomes are captured
  • landscape reviews and market assessment, including review of comparators, defining unmet need and identifying patient subpopulations for optimal turnover
  • developing country-specific pricing and reimbursement submissions including engagement with HTA authorities
  • presenting payer-relevant evidence through writing of global value dossiers including cost effectiveness and budget impact modelling
  • participation in advisory boards and expert focus groups
  • ongoing support with general questions regarding local markets